MDMA and brain activity during neurocognitive performance: An overview of neuroimaging studies with abstinent 'Ecstasy' users.

Roberts, Carl A; Quednow, Boris B; Montgomery, Catharine; Parrott, Andrew C

Roberts, Carl A; Quednow, Boris B; Montgomery, Catharine; Parrott, Andrew C.

Afiliação

Roberts CA; Department of Psychological Sciences, University of Liverpool, UK. Electronic address: Carl.roberts@liv.ac.uk.
Quednow BB; Experimental and Clinical Pharmacopsychology, Department of Psychiatry, Psychotherapy, and Psychosomatics, Psychiatric Hospital, University of Zurich, Zurich, Switzerland.
Montgomery C; School of Natural Sciences and Psychology, Liverpool John Moores University, UK.
Parrott AC; Department of Psychology, Swansea University, Swansea, UK; Centre for Human Psychopharmacology, Swinburne University, Melbourne, Australia.

Neurosci Biobehav Rev ; 84: 470-482, 2018 Jan.

Article em En | MEDLINE | ID: mdl-28801175

Assuntos

Encéfalo/fisiopatologia; Transtornos Cognitivos/fisiopatologia; N-Metil-3,4-Metilenodioxianfetamina/efeitos adversos; Transtornos Cognitivos/induzido quimicamente; Eletroencefalografia; Neuroimagem Funcional; Humanos; Testes Neuropsicológicos

Palavras-chave

Cognition; EEG; ERP; Ecstasy; MDMA; Memory; Neuroimaging; Neurotoxicity; Serotonin; fMRI; fNIRS

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encéfalo / Transtornos Cognitivos / N-Metil-3,4-Metilenodioxianfetamina Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google